Live
FierceBiotechNeuroVision acquires fellow dx player Durin Life SciencesBioPharma DiveFDA hold puts Aardvark Prader-Willi drug in limboBioPharma DiveSupreme Court preserves access to abortion pill by mailBioPharma DiveBiotech leaders campaign for Pazdur; Takeda to lay off 4,500 workersEndpoints NewsCandel reports prostate cancer drug's long-term data ahead of FDA filingEndpoints NewsPost-Hoc Live: Makary's out at FDA and what comes nextCellThe immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosisFierceBiotechNovartis, amid reorg, cuts ‘select number’ of biomedical research rolesPharmaVoiceSanofi’s vaccine bump; the new FDA commishEndpoints NewsAardvark's next move after clinical hold; Alumis' verdict on Acelyrin assetFierceBiotechWhy Model Medicines needs to ‘discover new colors’ in its AI drug discovery questThermo FisherDigital Quality Systems, AI, and the Future of Quality Oversight - Contract Pharma
BioPharma Dive Mar 31, 2026

Merck strikes deal with antibody discovery startup

Merck strikes deal with antibody discovery startup

Original
Body unavailable. Use the original source.